Adult antibody thresholds are currently used to determine whether immunocompromised children should get a measles, mumps, and ...

Expansion of government screening programs, rise in prevalence of hepatitis c & need for its early detection, and advancements in diagnostic technologies drive the growth of the global hepatitis C ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Hepatitis B and C still survive in the dark, driven by a lack of information, unhygienic medical procedures, and poor access ...

The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...

SAN FRANCISCO, CA, USA I March 13, 2025 I Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE ...

Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with a weakened ...

Neutralising antibodies can prevent severe courses Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with weakened immune system or existing ...

Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with ...

Nona Biosciences (Nasdaq: NONA) has introduced Hu-mAtrIx, an artificial intelligence (AI)-assisted drug discovery platform designed to accelerate the identification and development of antibody-based ...

With experience in diverse therapeutic modalities such as small molecules, antisense RNAi oligonucleotides, monoclonal antibodies, vaccines, proteins, and peptides. The Hepatitis B - Global ...